a76df2f9_docrine_Cancer_Research___CFCF__Status
[Title] A Phase I Trial of the mTOR Inhibitor RAD001 in Combination With VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 in Patients With Advanced Solid Tumors [Phase] I [Conditions] Neuroendocrine Tumor Pancreatic Neuroendocrine Tumor Pulmonary Carcinoid [State] MN [Status] 
Not Recruiting
N o t R e c r u i t i n g
E n r o l l i n g
Clinical Trials Finder | Carcinoid and Pancreatic Neuroendocrine Cancer Research | CFCF
Status